The Children's Tumour Foundation of Australia (CTF), in conjunction with Whiteley Medical is proud to present the 2020 Neurofibromatosis Symposium featuring international keynote speaker Prof. Michael J Fisher, MD from the Children's Hospital of Philadelphia (CHoP); a specialist in brain tumours and Neurofibromatosis.
Prof. Fisher will be joined by 14 leading Australian researchers and clinicians who will provide information on the latest research, diagnosis and clinical treatments for both NF1 and NF2 patients.
Topics covered will include, MeK Inhibitors, stem cell research, gene therapy, muscle fatigue, breast screening, non-surgical treatment of NF2, laser therapy and other treatments for skin and disfigurement as well as the latest research on the social and developmental challenges faced by most children with NF.
* Please contact email@example.com for information about travel bursaries for those travelling interstate
EXTENDED SPEAKER LIST
Associate Professor Yemima Berman | Head, Department of Clinical Genetics at RNSH, President Australasian Association of Clinical Geneticists, MD Research Coordinator, University of Sydney Northern Clinical School (BMBS FRACP BSc Hons PhD Medicine Clinical Geneticist (HGSA))
(speaking alongside Dr Rebecca Saunderson | Dermatologist at RNSH, NSW Faculty Honorary Secretary ACD, BMedSci (hon1) MBBS (hon) MPhil (Cantab) FACD
TOPIC: Treatment of disfigurement in NF
Associate Professor Nigel Biggs | Chairman, Department of Otolaryngology, Head and Neck and Skull Base Surgery, St Vincent's Hospital, Sydney
TOPIC: NF2 treatment options
Dr Geoffrey McCowage MB, BS, FRACP | Senior Paediatric Oncologist, Children’s Hospital Westmead
TOPIC: MEK inhibitors in NF-1 related tumours: update and future research trials
Dr. Gautam Wali | Neuro Stem Cell Scientist, University of Sydney, The University of Sydney · Kolling Institute of Medical Research - PhD Neuroscience and Stem cell biology
TOPIC: Stem Cell Applications
Associate Professor Aaron Schindeler | Head of Bioengineering and Molecular Medicine (BAMM) Laboratory (Orthopaedic Research & Biotechnology Unit), Children's Hospital Westmead
TOPIC: Updates on L-Carnitine Therapy for NF1 and the Development of Gene Therapy Tools for NF treatment
Dr Belinda Barton | Department Head & Psychologist Children's Hospital Education Research Institute (CHERI), NF1 Neurocognitive Research Team Leader at Kids Neuroscience Centre, Conjoint Senior Lecturer at Sydney Medical School (USYD)
TOPIC: NF Learning Clinic Learning Difficulties Studies
Dr Samantha Ginn | Senior Research Officer in the Gene Therapy Research Unit of the Children’s Medical Research Institute
TOPIC: Towards a vector-based universal genome editing approach for the treatment of Neurofibromatosis Type 1 (NF1)
Dr Katrina Morris | BMedSci MBBS (Hons) PhD FRACP, Neurologist at Royal North Shore Hospital
TOPIC: Non-surgical NF2 treatments
Dr. Jonathan Payne | DPsych, Co-Group Leader/Senior Research Fellow, Brain and Mind, Murdoch Children's Research Institute, Senior Clinical Neuropsychologist, Mental Health, The Royal Children's Hospital, Honorary Senior Fellow, Department of Paediatrics, The University of Melbourne
Murdoch Children's Research Institute
TOPIC: Social Skills and Autism Research
Matilda Wilding (RNS) and Breast Surgeon Katrina Moore
TOPIC: Breast screening in NF
Lauren Taylor/Alice Maier | Research Psychologist at MCRI
TOPIC: Severity Scale/Audiology Studies/Speech
The goal of this symposium is to bring together researchers and clinicians with the intention of sharing current research and knowledge and improving collaboration in this diverse clinical community, that will ideally lead to improved health care for patients with this genetic disorder.
This event is proudly sponsored by